Literature DB >> 33350379

Outcome of Japanese Encephalitis Virus (JEV) Infection in Pediatric and Adult Patients at Mahosot Hospital, Vientiane, Lao PDR.

Mayfong Mayxay1,2,3, Phouvieng Douangdala4, Chanthala Vilayhong1, Koukeo Phommasone1, Vilada Chansamouth1, Manivanh Vongsouvath1, Sayaphet Rattanavong1, Ko Chang1, Onanong Sengvilaipaseuth1, Anisone Chanthongthip1, Soulignasack Thongpaseuth1, Paul N Newton1,3, Audrey Dubot-Pérès1,3,5.   

Abstract

Although Japanese encephalitis virus (JEV) infection is an important cause of acute febrile illness in Lao PDR (Laos), patient outcome has not been evaluated. We prospectively followed up 123 JEV-infected patients (70 children < 15 years and 53 adults ≥ 15 years) admitted at Mahosot Hospital, Vientiane, from 2003 to 2013. Japanese encephalitis virus infection was diagnosed by the detection of anti-JEV IgM in cerebrospinal fluid and/or IgM seroconversion. Neurological sequelae were assessed using the Liverpool Outcome Score (LOS), total (maximum score = 75), and final (maximum score = 5). The median (interquartile range [IQR]) age of the patients was 12.0 (7.5-18.8) years, and 57% were male. The median (IQR) duration of patients' follow-up was 4.5 (3.2-7.3) years. Of all patients, 10/123 (8.1%) died during hospitalization, and 13/123 (10.6%) died at home after discharge, giving a mortality of 18.7% (23/123) (33 [26.8%] patients were lost to follow-up). The frequency of neurological sequelae at the last follow-up was 61.2% (48.4% in adults and 69.4% in children, P = 0.135). The proportion of patients with severe and moderate functional impairment at the last follow-up was significantly higher in children (25%) than in adults (6.5%), P = 0.042. Half of the patients who were still alive at the last follow-up (67) and for whom LOS data were available (22) had improvements in their total and final LOS between discharge and the last follow-up. The total and final LOS at discharge were not significantly different between children and adults, but total LOS at the last follow-up was significantly higher in adults than in children (median [IQR]: 74.5 [73-75] versus 73.0 [73-75], P = 0.019).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33350379      PMCID: PMC7866311          DOI: 10.4269/ajtmh.20-0581

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  The epidemiology and disease burden of children hospitalized for viral infections within the family Flaviviridae in China: A national cross-sectional study.

Authors:  Ran Wang; Xinyu Wang; Linlin Zhang; Guoshuang Feng; Mengjia Liu; Yueping Zeng; Zhengde Xie
Journal:  PLoS Negl Trop Dis       Date:  2022-07-05

Review 2.  Acute neurologic emerging flaviviruses.

Authors:  Marissa Caldwell; Abhilasha P Boruah; Kiran T Thakur
Journal:  Ther Adv Infect Dis       Date:  2022-06-13

3.  Estimates of Japanese Encephalitis mortality and morbidity: A systematic review and modeling analysis.

Authors:  Yuwei Cheng; Nhat Tran Minh; Quan Tran Minh; Shreya Khandelwal; Hannah E Clapham
Journal:  PLoS Negl Trop Dis       Date:  2022-05-25

4.  Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia.

Authors:  Nazmul Islam; Colleen Lau; Alan Leeb; Deborah Mills; Luis Furuya-Kanamori
Journal:  Hum Vaccin Immunother       Date:  2022-03-07       Impact factor: 3.452

5.  Modelling Japanese encephalitis virus transmission dynamics and human exposure in a Cambodian rural multi-host system.

Authors:  Héléna Ladreyt; Véronique Chevalier; Benoit Durand
Journal:  PLoS Negl Trop Dis       Date:  2022-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.